Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility

Authors:

Abstract
This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.
Funding Information
  • Kræftens Bekæmpelse

This publication has 43 references indexed in Scilit: